chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LOW BLOOD SUGAR BELOW 30 FOR THE PAST 2 WEEKS AFTER RECEIVING THE JANSSEN VACCINE; This spontaneous report received from a parent concerned a 24-year-old white and not Hispanic or Latino female. The patient's weight was 115 pounds, and height was 50 inches. The patient's concurrent conditions included diabetes type I, diabetic ketoacidosis, nonsmoker, nonalcoholic, developmentally delayed, cyclic vomiting, gastroparesis, hernia hiatal, esophagitis, acid reflux, Gastroesophageal reflux disease, and regular migranes. Patient had no known allergies. The patient had no drug abuse or illicit drug usage. Patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: 23-JUN-2021) dose was not reported, 1 total administered on 18-MAY-2021 on left arm for prophylactic vaccination. Concomitant medications included insulin aspart for diabetic ketoacidosis.  On 16-MAY-2021 the patient was being admitted to hospital for diabetic ketoacidosis. After receiving vaccine patient started having very low blood sugar. Patient was on daily medications of Novolog Insulin using Pump with sensor for Keto acidosis. On 19-MAY-2021, the patient experienced low blood sugar below 30 for the past 2 weeks after receiving the janssen vaccine. Laboratory data (dates unspecified) included: Blood sugar decreased (NR: not provided) as below 30. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low blood sugar below 30 for the past 2 weeks after receiving the janssen vaccine. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210601568-COVID-19 VACCINE AD26.COV2.S- low blood sugar below 30 for the past 2 weeks after receiving the janssen vaccine. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: CONMEDS-OTHER SUSPECT DRUGS, MEDICAL HISTORY.
Administered vaccines, within 5 minutes after, patient fainted for about 15 seconds before coming to.
The patient asked "does rheumatoid arthritis count to make me higher risk"; A 46 year old patient received PNEUMOVAX23; This spontaneous report was received from a 46-year-old patient of unknown gender reporter on him ot herself. The patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapy were not reported.      On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, lot #, expiration date and route were not reported) for prophylaxis (product administered to patient of inappropriate age).         On an unknown date, the patient asked, "does rheumatoid arthritis count to make me higher risk"(rheumatoid arthritis). There was no product quality complain.  At the time of the report, the outcome of rheumatoid arthritis was not reported.    The reporter considered rheumatoid arthritis to be related to Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23).     Upon internal review, rheumatoid arthritis was determined to be medically significant.
Kind of warm to touch; "rash at the site of injection about 2/1 in; rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender"; Normal sore arm; Red rash around side area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Normal sore arm), RASH ERYTHEMATOUS (Red rash around side area), VACCINATION SITE WARMTH (Kind of warm to touch), VACCINATION SITE RASH ("rash at the site of injection about 2/1 in) and VACCINATION SITE PAIN (rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender") in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Overweight and Blood pressure (Blood pressure is high.).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Normal sore arm) and RASH ERYTHEMATOUS (Red rash around side area). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Kind of warm to touch), VACCINATION SITE RASH ("rash at the site of injection about 2/1 in) and VACCINATION SITE PAIN (rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender"). At the time of the report, PAIN IN EXTREMITY (Normal sore arm), RASH ERYTHEMATOUS (Red rash around side area), VACCINATION SITE WARMTH (Kind of warm to touch), VACCINATION SITE RASH ("rash at the site of injection about 2/1 in) and VACCINATION SITE PAIN (rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included pills for overweight, high blood pressure Treatment information was not provided
7/29/21: He noticed he started coughing and went to the walk in clinic on 7/29/21 and his Covid test resulted in positive on 7/29/21. At that time, he was instructed to monitor outpatient.  8/3/21: His symptoms were not improving. He came to Hospital on 8/3/21 and was hospitalized. He was discharged the following day 8/4/2021.  Note: He had COVID Pfizer vaccines at his work on 03/04/2021 and 03/25/2021.
77-year-old male presents to the emergency department with shortness of breath and fever.  He denies any chest pain or palpitations.  He denies any syncopal episodes.  He states his wife was diagnosed with COVID-19 infection after having similar symptoms a few days ago.  He does state that he and his wife both received the Johnson & Johnson vaccination
Little bit swollen and sore shoulder; Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Little bit swollen and sore shoulder) and ARTHRALGIA (Sore shoulder) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Little bit swollen and sore shoulder) and ARTHRALGIA (Sore shoulder). At the time of the report, SWELLING (Little bit swollen and sore shoulder) and ARTHRALGIA (Sore shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
While in waiting area client experienced loss of consciousness and seizure-like activity lasting approximately 48 seconds per nurse that responded to incident.  Loss of bladder control noted.  Squad responded and transported patient to the hospital via ambulance.  Patient was coherent prior to transport.  He states he was admitted to the hospital and Observation x 24 hours.  He had a CT scan and bloodwork, both normal.  Neurologist at the hospital told him he experienced syncope and no seizure activity was suspected.  He states a history of feeling faint when he sees blood.  He sates the Neurologist advised he get the second dose and lay down after the shot.
Above person received the H1N1 vaccine, within 2 hours reported inability to lift arm, pain from elbow to hand.  Has also developed swelling to hand (R) (unable to put on rights).  Also reported no fever but constant "chills".  Has appt with orthopedic spec. on 12/4.
Information has been received from a consumer concerning her 14 year old daughter who on 29-JUL-2010, was vaccinated with a dose of GARDASIL. There was no concomitant medication. It was reported that on 29-JUL-2010, 20 minutes after receiving GARDASIL, the patient fainted. The patient recovered five minutes after fainting. Follow-up information has been received from a consumer concerning her daughter with no known drugs reactions or allergies and no illness at the time of vaccination who on 29-JUL-2010, was vaccinated with a first dose of GARDASIL (Lot number 662559/1178Y) into her right deltoid. On 29-JUL-2010 she fainted in car after shot. On 29-JUL-2010 she recovered from fainted. The patient did not seek medical attention. No further information is available.
I woke up and  had chills, headache, fever, and weakness. I did not seek medical care and I did recover in under 24 hrs. 16-18 hours.
Patients states he started feeling blockage in the right side of his nose, patient could not close right eye with using his hand, patient mouth dropped to left side. Patient has been diagnosed with Bells Palsy. 02/15/07-records received and reviewed for DOS 01/30/07.  Chief complaint-right side of face, nostril feel strange patient states that the right eye cannot close without his assistance, also mouth drops down to the left. Started 2 days after receiving Menactra. PE:WNL WNL except for Cranial nerves-normal facial sensation, intact corneal reflexes, Bell's palsy noted with reduced left facial movement and loss of right forehead wrinkling, normal hearing bilaterally, palate is midline tongue is midline. Assessment:Patient's Bell's palsy has worsened. To call office with concerns for changes.
I had extreme fatigue, bodyaches, headaches, nausea, fever of 100.4, and the site swelled and had a reddened area of 6cm
This spontaneous report was received from a registered nurse regarding a 12 month old patient of unknown gender. The patient's concomitant medications included HAVRIX and sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were not provided). The patient's medical history, concurrent conditions and drug reactions/allergies were not provided. On an unspecified date, the patient was mistakenly vaccinated with PROQUAD injection, lot # N025929, expiration date 18-MAR-2019 (frequency, route and anatomical location were not provided) and VARIVAX injection, lot # N026999 expiration date 28-SEP-2019, both for prophylaxis (frequency, route and anatomical location were not provided). The mistake was discovered on 12-MAR-2018. No adverse effects reported.
* not sure what strand of the influenza was given, my son got his immunizations and shortly after turned gray/white in the face, eyes rolled back and his head dropped, he started to shake and the medical assistant and I helped him down to the ground, the doctor then came into the room, we propped his legs up, his blood went back, color got slightly better, he started to regain consciousness.
Transfer from outside facility after a fall, concern for odontoid fracute .Fever, cough - covid was neg on admissionCOVID pos  01/11 Mild symptoms,zinc, singulair
Pt had a flu shot at the pharmacy on Monday 10/6/2023. She called on Tuesday saying that she slept on her injection site all night long and when she woke up she noticed that she has a swelling at her lower upper shoulder close to the injection site. When she called up, she said that the swelling has been reduced some since the previous day. I asked her to go to the ER or doctor, she said that she would rather show it to us first. She came on Thursday 10/12/2023. 2 pharmacists evaluated the swelling. Pt said that it has been reducing from Monday. She had no warmth skin, no fever, no N/V. She decided to continue to keep an eye on the swelling and will update us if any changes. I called her on Saturday, she said that the swelling has been down and diminished. She said that she will follow up with her doctor. I confirmed that it will be the best to do. and Let us know it we can be in any way to help. Pt said that she had a burger on Saturday, and she noticed that her lips swelled after eating. Informed her to go the ER if it is an allergic reaction of some sort.
Patient reports long history of taking ibuprofen/NSAIDS.  After 2nd dose of vaccine 2/2/21 she took took ibuprofen about 27-28 hours later on 2/3/21 due to aches/headache.  She developed face/lip swelling and tingling.  She was seen by provider via video visit and told she needed to be seen in person.  She went to urgent care and was prescribed EpiPen PRN.  On 2/22/2021 she was having some back-pain and took ibuprofen.  About 1 hour later she developed same response with face swelling/tingling.  She does feel her reaction is caused by the ibuprofen but she reports this being a new reaction since the vaccine since she routinely took ibuprofen prior to the vaccine.
heart issues; heart inflammation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Oct2021 18:40 (Lot number: FF2590) at the age of 47 years as dose 1, single and administered in arm right, administration date 13Nov2021 18:40 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "heart issues"; INFLAMMATION (non-serious), outcome "unknown", described as "heart inflammation". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received an undiluted pfizer orange cap 0.2 mL into the right arm. Pt is doing okay and no signs or symptoms of distress/ illness at this time.
Onset of itching of back at first on December 11 2021 at 3 am on December 14 2021 onset of fever, severe headache and shingles rash left chest
Got shingrix vaccine at an unknown time in the past / Diagnosed with shingles/Suspected vaccination failure; Diagnosed as shingles; Rash on his foot; This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.  Co-suspect products included COVID-19 VACCINE (COVID 19 VACCINE) for prophylaxis and COVID-19 VACCINE (COVID 19 VACCINE) for prophylaxis.   On an unknown date, the patient received Shingrix, the 1st dose of COVID 19 VACCINE and the 2nd dose of COVID 19 VACCINE. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure, shingles and rash were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix vaccine at an unknown time in the past and had recently got Covid vaccine 1st and second dose. Two days after the second dose of coronavirus vaccine, the patient developed a rash on foot which provider diagnosed as shingles.  This case was considered as suspected vaccination failure, since the details regarding completion of the primary immunization for shingles, time to onset and laboratory confirmation for herpes zoster were not provided. The reporter had limited information and no other additional information was available. The reporter did not consent to follow up.
2.5 hours after 2nd dose started having lower abdominal pain. Pain significantly increased the next day.  Red small petechiae like dots on right side of upper back/shoulder. Arm swelled, hard, itchy, and hot to touch within 2 hours. Extreme joint pain. Severe dizziness and complete loss of appetite for 2 days.  Developed mood swings and irritability 6 hours after injection.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 24-JUL-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L000454 with exp. 06-JAN-2017, (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
roughly 2 weeks after my 2nd dose I got bad left wrist pain, made my wrist very weak could not put pressure on it: now it is intermittent, it comes and goes as if it is now a flare up. Left ovary pain as well
Swollen lymph nodes; cold chills; headaches; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 18:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) in the left arm on 03Apr2021 at 16:00 (at the age of 33-years-old) as a single dose for Covid-19 immunisation.  On 30Apr2021 the patient experienced swollen lymph nodes, cold chills and headaches. Therapeutic measures were not taken as a result of reported events.  Since the vaccination, the patient had been tested for COVID-19. On unknown date in 2021, patient underwent lab test and procedure which included Nasal swab COVID-19 test and the result was negative. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes, cold chills and headaches. was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Acute respiratory failure  Pt has mild hypoxia. Plan: lovenox per IM  oxygen saturation was 94% on RA  - does not qualify for monoclonal ab d/t hypoxia  - hold off decadron and remdesvir now  - if hypoxia worsens will start decadron, remdesvir - covid isolation
Red & warm to the touch. Redness spread. Mom gave tylenol & benadryl. Also some swelling. Told to treat with Ibuprofen, oral benadryl, cool compresses. Mark the spot & follow up if there is spreading. Also come in if a fever develops or other concerns arose.
pt was crying & stopped breathing became limp, cyanotic, rash, mild diarrhea;
Localized reaction with induration at site of injection. Diffuse papular rash over back, thighs and chest. Rash started, 2 days, post vax. No treatment.
Two days after vac. left arm could not lift. Lasted another day then could not move right arm. Has continued to move back and forth between arms, hands, knees, legs, wrists, ankles, sore throat every several days. Right and left fingers. Left eye blurry. Two separate days was not able to walk without assistance. 1-6-15-ongoing.
Rash extending from injection site down upper arm approximately 6 inches. A bruise formed where the rash ended. Extreme soreness, headache and nausea.
Pt was COVID negative on admission on 1/5.  Pt has a past medical history of COPD and alcoholic cirrhosis.  The pt was COVID tested on 1/11 for inpatient hospice placement and was positive.
This happen in store warehouse (work clinic) she got her 1st dose of Pfizer vaccine, she was waiting the 15 minutes and while waiting she was feeling dizzies and she felt. Patient went to the ER and they administer Tdap vaccine. We call her on (8-26-21) and she is felling okay.
Pt recv vax on 10/8/98; on 10/9/98 pt exp nausea
Soreness" like a bruise" at left deltoid onset directly afterward and still present. Rates 5 on pain scale 1-10. Pain noted with lesions. Numbness 1st, 2nd, 3rd finger and thumb onset 1/29/2010.
March 23, 2023 I suffered a near-fatal Thoracic Ascending Aneurysm due to interior surface dissection / damage to the aorta.  I required an ambulance.  This damage is present in CT scans down to the height of my kidneys.  I required emergency open-heart surgery on my Ascending Aorta.  The damaged section required it be replaced with rubber tubing, as indicated in the medical report for the surgery.  I am currently undergoing periodic monitoring for the damage done to my Lower / Descending Aorta.  It is highly expected that I will need a stent (another surgery).  Additionally, as a result of the emergency surgery, my right brachial plexus nerve was damage, as shown on an electromyogram, causing significant and likely permanent weakness in my right bicep and chest.     All blood samples indicated that I was not obese (BMI >40%), did NOT have high blood sugar, did NOT drink or use drugs, I was NOT under the effects of any prescription, did NOT have high cholesterol and, was of good physical strength and endurance.  The only thing I did medically different was take that injection because of "No Jab No Job" mandate, which should be as illegal as any male boss telling a subordinate, "No Head No Bread"!
received Pneumo 23 in right arm and  flushot in the left arm at Pharmacy at about 5:15-5:30 sat afternoon                                  I had a reasction at about 8pm -9:15pm I became very dizzy and started to faint.  I could barely crawl outside my upstairs bedroom to call for help. it took all my strength to get off the floor and fall onto my bed while vomiting somewhat uncontrollably.   I cannot recall a time that I have ever been that weak or sick before. At times, the reaction seemed potentially life-threatening.
Pain in hands/swelling; swelling in legs; Hosp. admit due to DVT in leg. Multiple physician appointments for leg/hand swelling and pain; labs. Physician diagnosed related to H1N1 vaccine.
Chills (resolved within 12 hours), pain in arm at injection site (ongoing), lethargy (lasted ~24 hours)
Swelling, redness and rash at injection site that occurred  4 days after receiving first injection.
PATIENT REPORTS SUFFERING A SEIZURE THE DAY AFTER RECEIVING SECOD DOSE OF SHINGRIX.  PATIENT ALSO REPORTS EXPERIENCING BLURRED VISION AND HEADACHES.  NONE OF THIS OCCURED AFTER THE FIRST DOSE.  PATIENT STATES HE HAS FULLY RECOVERED.
Kidney Stone after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of NEPHROLITHIASIS (Kidney Stone after the first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Kidney disorder.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, the patient experienced NEPHROLITHIASIS (Kidney Stone after the first dose) (seriousness criterion medically significant). The patient was treated with CIPROFLOXACIN at a dose of UNK, bid. At the time of the report, NEPHROLITHIASIS (Kidney Stone after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.  Company Comment  Very limited information regarding the event has been provided at this time. Reporter did not provide permission to follow-up.; Sender's Comments: Very limited information regarding the event has been provided at this time. Reporter did not provide permission to follow-up.